Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Oct-12 4:13 PM View:  | Haughey Thomas President Director | Par Pharmaceutical Companie... (PRX) | 28-Sep-12 | Disposition | 900 | $50.00 | $45,000.00 | (100%) 0.9K to 0 | |
| 02-Oct-12 5:00 PM View: | Lepore Patrick G Executive Chairman Director | Par Pharmaceutical Companie... (PRX) | 28-Sep-12 | Disposition | 38,000 | $50.00 | $1,900,000.00 | (100%) 38.0K to 0 | |
| 02-Oct-12 6:05 PM View: | Knight Peter S Director | Par Pharmaceutical Companie... (PRX) | 28-Sep-12 | Disposition | 3,500 | $50.00 | $175,000.00 | (100%) 3.5K to 0 | |
| 02-Oct-12 3:45 PM View: | Campanelli Paul Chief Executive Officer Director | Par Pharmaceutical Companie... (PRX) | 28-Sep-12 | Disposition | 46,017 | $50.00 | $2,300,850.00 | (100%) 46.02K to 0 | |
| 02-Oct-12 4:33 PM View: | Tropiano Michael A EVP and Chief Financial Office | Par Pharmaceutical Companie... (PRX) | 28-Sep-12 | Disposition | 57,250 | $50.00 | $2,862,500.00 | (100%) 57.25K to 0 | |
| 02-Oct-12 4:13 PM View: | Haughey Thomas President Director | Par Pharmaceutical Companie... (PRX) | 28-Sep-12 | Disposition | 69,648 | $50.00 | $3,482,400.00 | (99%) 70.55K to 0.9K | |
| 02-Oct-12 5:00 PM View: | Lepore Patrick G Executive Chairman Director | Par Pharmaceutical Companie... (PRX) | 28-Sep-12 | Disposition | 191,792 | $50.00 | $9,589,600.00 | (83%) 229.79K to 38.0K | |
| 02-Oct-12 5:50 PM View: | Nordmann Ronald M Director | Par Pharmaceutical Companie... (PRX) | 28-Sep-12 | Disposition | 4,000 | $50.00 | $200,000.00 | (100%) 4.0K to 0 | |
| 02-Oct-12 6:19 PM View: | Smith Joseph E Director | Par Pharmaceutical Companie... (PRX) | 28-Sep-12 | Disposition | 70,000 | $50.00 | $3,500,000.00 | (100%) 70.01K to 9 | |
| 24-Jul-12 6:22 PM View: | Tropiano Michael A Executive Vice President & CFO | Par Pharmaceutical Companie... (PRX) | 23-Jul-12 | Payment of Exercise | 624 | $50.19 | $31,318.60 | (1%) 57.87K to 57.25K | 0% |
| 17-May-12 5:45 PM View: | Tropiano Michael A EVP and CFO | Par Pharmaceutical Companie... (PRX) | 16-May-12 | Payment of Exercise | 903 | $40.34 | $36,427.00 | (2%) 58.78K to 57.87K | 0% |
| 21-Mar-12 5:55 PM View: | Knight Peter S Director | Par Pharmaceutical Companie... (PRX) | 19-Mar-12 | Option Exercise | 7,500 | $28.79 | $215,925.00 | 214% 3.5K to 11.0K | |
| 21-Mar-12 5:55 PM View: | Knight Peter S Director | Par Pharmaceutical Companie... (PRX) | 19-Mar-12 | Market Option Sale | 7,500 | $37.02 | $277,675.00 | (68%) 11.0K to 3.5K | 2% |
| 21-Mar-12 5:42 PM View: | Nordmann Ronald M Director | Par Pharmaceutical Companie... (PRX) | 19-Mar-12 | Option Exercise | 7,500 | $28.79 | $215,925.00 | 188% 4.0K to 11.5K | |
| 21-Mar-12 5:42 PM View: | Nordmann Ronald M Director | Par Pharmaceutical Companie... (PRX) | 19-Mar-12 | Market Option Sale | 7,500 | $37.03 | $277,743.00 | (65%) 11.5K to 4.0K | 2% |
| 13-Jan-12 4:54 PM View: | Campanelli Paul Chief Operating Officer | Par Pharmaceutical Companie... (PRX) | 11-Jan-12 | Payment of Exercise | 1,102 | $35.65 | $39,286.30 | (2%) 47.21K to 46.11K | (< 1%) |
| 13-Jan-12 5:12 PM View: | Tropiano Michael A EVP and CFO | Par Pharmaceutical Companie... (PRX) | 11-Jan-12 | Payment of Exercise | 482 | $35.65 | $17,183.30 | (< 1%) 59.26K to 58.78K | (< 1%) |
| 13-Jan-12 5:07 PM View: | Haughey Thomas President | Par Pharmaceutical Companie... (PRX) | 11-Jan-12 | Payment of Exercise | 1,017 | $35.65 | $36,256.10 | (1%) 71.56K to 70.55K | (< 1%) |
| 13-Jan-12 5:02 PM View: | Lepore Patrick G Chairman and CEO Director | Par Pharmaceutical Companie... (PRX) | 11-Jan-12 | Payment of Exercise | 1,652 | $35.65 | $58,893.80 | (< 1%) 231.44K to 229.79K | (< 1%) |
| 11-Jan-12 5:50 PM View: | Lepore Patrick G Chairman and CEO Director | Par Pharmaceutical Companie... (PRX) | 09-Jan-12 | Payment of Exercise | 5,365 | $35.09 | $188,258.00 | (2%) 236.81K to 231.44K | (3%) |
| 11-Jan-12 5:41 PM View: | Tropiano Michael A EVP and CFO | Par Pharmaceutical Companie... (PRX) | 09-Jan-12 | Payment of Exercise | 481 | $35.09 | $16,878.30 | (< 1%) 59.74K to 59.26K | (3%) |
| 09-Jan-12 6:08 PM View: | Haughey Thomas President | Par Pharmaceutical Companie... (PRX) | 06-Jan-12 | Payment of Exercise | 744 | $34.01 | $25,303.40 | (1%) 72.31K to 71.56K | 0% |
| 09-Jan-12 5:56 PM View: | Tropiano Michael A EVP & CFO | Par Pharmaceutical Companie... (PRX) | 06-Jan-12 | Payment of Exercise | 687 | $34.01 | $23,364.90 | (1%) 60.43K to 59.74K | 0% |
| 09-Jan-12 6:20 PM View: | Campanelli Paul Chief Operating Officer | Par Pharmaceutical Companie... (PRX) | 06-Jan-12 | Payment of Exercise | 806 | $34.01 | $27,412.10 | (2%) 47.92K to 47.12K | 0% |
| 09-Jan-12 5:56 PM View: | Tropiano Michael A EVP & CFO | Par Pharmaceutical Companie... (PRX) | 05-Jan-12 | Grant | 11,447 | -- | -- | 23% 48.98K to 60.43K | |
| 06-Jan-12 5:19 PM View: | Lepore Patrick G Chairman and CEO Director | Par Pharmaceutical Companie... (PRX) | 04-Jan-12 | Payment of Exercise | 2,941 | $32.17 | $94,612.00 | (1%) 239.75K to 236.81K | (2%) |
| 06-Jan-12 5:10 PM View: | Campanelli Paul Chief Operating Officer | Par Pharmaceutical Companie... (PRX) | 04-Jan-12 | Payment of Exercise | 1,062 | $32.17 | $34,164.50 | (2%) 48.99K to 47.92K | (2%) |
| 06-Jan-12 5:03 PM View: | Haughey Thomas President | Par Pharmaceutical Companie... (PRX) | 04-Jan-12 | Payment of Exercise | 1,057 | $32.17 | $34,003.70 | (1%) 73.37K to 72.31K | (2%) |
| 06-Jan-12 4:55 PM View: | Tropiano Michael A EVP and CFO | Par Pharmaceutical Companie... (PRX) | 04-Jan-12 | Payment of Exercise | 340 | $32.17 | $10,937.80 | (< 1%) 50.32K to 49.98K | (2%) |
| 19-Dec-11 2:57 PM View: | Knight Peter S Director | Par Pharmaceutical Companie... (PRX) | 15-Dec-11 | Market Option Sale | 2,500 | $32.51 | $81,284.50 | (42%) 6.0K to 3.5K | 1% |
| 19-Dec-11 2:42 PM View: | Nordmann Ronald M Director | Par Pharmaceutical Companie... (PRX) | 15-Dec-11 | Option Exercise | 2,500 | $29.90 | $74,750.00 | 62% 4.0K to 6.5K | |
| 19-Dec-11 2:42 PM View: | Nordmann Ronald M Director | Par Pharmaceutical Companie... (PRX) | 15-Dec-11 | Market Option Sale | 2,500 | $32.50 | $81,250.30 | (38%) 6.5K to 4.0K | 1% |
| 19-Dec-11 2:57 PM View: | Knight Peter S Director | Par Pharmaceutical Companie... (PRX) | 15-Dec-11 | Option Exercise | 2,500 | $29.90 | $74,750.00 | 71% 3.5K to 6.0K | |
| 22-Nov-11 5:18 PM View: | Campanelli Paul Chief Operating Officer | Par Pharmaceutical Companie... (PRX) | 21-Nov-11 | Payment of Exercise | 7,009 | $29.56 | $207,186.00 | (12%) 56.8K to 49.79K | 1% |
| 22-Nov-11 5:29 PM View: | Haughey Thomas President | Par Pharmaceutical Companie... (PRX) | 21-Nov-11 | Payment of Exercise | 6,589 | $29.56 | $194,771.00 | (8%) 79.95K to 73.37K | 1% |
| 07-Sep-11 2:39 PM View: | Lepore Patrick G Chairman, President & CEO Director | Par Pharmaceutical Companie... (PRX) | 06-Sep-11 | Market Purchase | 8,000 | $25.92 | $207,360.00 | 3% 284.88K to 292.88K | 4% |
| 07-Sep-11 2:43 PM View: | Tropiano Michael A EVP & CFO | Par Pharmaceutical Companie... (PRX) | 06-Sep-11 | Market Purchase | 2,000 | $27.50 | $55,000.00 | 4% 47.32K to 49.32K | (2%) |
| 10-Aug-11 5:26 PM View: | Lepore Patrick G Chairman, President & CEO Director | Par Pharmaceutical Companie... (PRX) | 09-Aug-11 | Payment of Exercise | 8,690 | $29.09 | $252,792.00 | (3%) 293.57K to 284.88K | 0% |
| 25-Jul-11 3:09 PM View: | Tropiano Michael A EVP & CFO | Par Pharmaceutical Companie... (PRX) | 21-Jul-11 | Payment of Exercise | 780 | $34.61 | $26,995.80 | (2%) 48.1K to 47.32K | < 1% |
| 18-May-11 5:33 PM View: | Tropiano Michael A EVP & CFO | Par Pharmaceutical Companie... (PRX) | 16-May-11 | Grant | 10,794 | -- | -- | 29% 37.31K to 48.1K | |
| 11-May-11 6:17 PM View: | Haughey Thomas EVP, CAO, General Counsel | Par Pharmaceutical Companie... (PRX) | 10-May-11 | Option Exercise | 26,800 | $13.06 | $350,008.00 | 34% 79.95K to 106.75K | |
| 11-May-11 6:17 PM View: | Haughey Thomas EVP, CAO, General Counsel | Par Pharmaceutical Companie... (PRX) | 10-May-11 | Market Option Sale | 26,800 | $35.55 | $952,727.00 | (25%) 106.75K to 79.95K | (< 1%) |
| 11-May-11 4:34 PM View: | Lepore Patrick G Chairman, President & CEO Director | Par Pharmaceutical Companie... (PRX) | 09-May-11 | Option Exercise | 65,467 | $13.06 | $854,999.00 | 22% 293.57K to 359.04K | |
| 11-May-11 5:39 PM View: | Haughey Thomas EVP, CAO, General Counsel | Par Pharmaceutical Companie... (PRX) | 09-May-11 | Option Exercise | 68,591 | $10.99 | $753,815.00 | 59% 116.86K to 185.45K | |
| 11-May-11 5:39 PM View: | Haughey Thomas EVP, CAO, General Counsel | Par Pharmaceutical Companie... (PRX) | 09-May-11 | Market Option Sale | 68,491 | $34.93 | $2,392,650.00 | (37%) 185.55K to 117.06K | (2%) |
| 11-May-11 5:39 PM View: | Haughey Thomas EVP, CAO, General Counsel | Par Pharmaceutical Companie... (PRX) | 09-May-11 | Market Sale | 38,002 | $34.93 | $1,327,550.00 | (32%) 117.06K to 79.06K | (2%) |
| 11-May-11 4:34 PM View: | Lepore Patrick G Chairman, President & CEO Director | Par Pharmaceutical Companie... (PRX) | 09-May-11 | Market Option Sale | 65,467 | $34.17 | $2,236,970.00 | (18%) 359.04K to 293.57K | (4%) |
| 11-May-11 5:39 PM View: | Haughey Thomas EVP, CAO, General Counsel | Par Pharmaceutical Companie... (PRX) | 09-May-11 | Market Option Sale | 100 | $34.47 | $3,447.00 | < 1% 185.45K to 185.55K | 3% |
| 24-Mar-11 5:39 PM View: | Tropiano Michael A EVP and CFO | Par Pharmaceutical Companie... (PRX) | 22-Mar-11 | Payment of Exercise | 787 | $29.00 | $22,823.00 | (2%) 38.09K to 37.31K | < 1% |
| 24-Mar-11 5:23 PM View: | Campanelli Paul EVP, Pres-Par Pharmaceutical | Par Pharmaceutical Companie... (PRX) | 22-Mar-11 | Payment of Exercise | 3,039 | $29.00 | $88,131.00 | (5%) 59.84K to 56.8K | < 1% |
